Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for confirming that, been a long day and lots of info provided on that call.
With the low float it will be quite obvious once Institutions start buying in leading up to the IPO.
Gerald wants AMBS to be a Therapeutics Company and is certainly steering the ship that direction.
The stage is set. Looking forward to getting the RS behind us and onto the NASDAQ. Institution Investors await, lets get them on board.
This was the most detailed I have heard Gerald be on any conference call, it was refreshing.
I think once the diagnostics have all been sold off AMBS will be only a Therapeutics company and drop the Holdings part at that time. Just my opinion.
I believe GC said they are under a NDA regarding the data since companies are doing their DD regarding Lympro. The AAIC conference is July 18 - 23. Sounds like they are very positive about the data and we will hear more about it at that time.
Also the Georgetown folks might be presenting their data at that conference also.
Yes, best AMBS conference call to date in my opinion. All aboard for the institutional investors and NASDAQ.
Institutions are interested and will be/can buy in post split prior to the IPO'ing onto the NASDAQ.
Once AMBS is on the NASDAQ we will likely see the DX IPO onto the NASDAQ also if that division isn't sold first.
And with the tiny float post split, this could really move.
See below issued by the company this month. AMBS is keeping its shareholders updated. It's safe to assume by the time frame additional information was requested.
Page 23 and 27
http://content.stockpr.com/amarantus/media/3b975cd360749a34eb202bd4c0121792.pdf
Indeed it would be. MANF is certainly the cornerstone here.
I wouldn't be surprised to hear about the NJ tax credits since AMBS has a firm working to sell them.
I think the best we could hope for is an institutional investor or a partnership for Eltoprazine. Either of those would have a dramatic affect on the PPS post split.
You are, but most of us have known that.
Anything under .05 is being bought up when available....
The 20 days is only the "D" on the ticker.
As a result of the stock split, every 150 shares of issued and outstanding common stock will be converted into 1 share of common stock. Upon FINRA approval the Company's common stock will temporarily trade on the OTCQB under the symbol "AMBSD," for a period of 20 trading days after which time the symbol will revert back to AMBS. The temporary "D" at the end of the Company's stock symbol signifies that the reverse stock split has occurred. Following the reverse split, there will be approximately 7 million common shares outstanding.
Not true! This is were the 20 days number comes from. However if my memory is correct there maybe 1 to 3 days that you will be unable to sell shares you had prior to the split. This happens sometimes because conversion from old shares to the "new shares" under the CUSIP number hasn't been completed. I am not sure if it happens with all brokers or with every RS.
100% agreed with that. I have little doubt that GC is doing what is best for the company. I only question and am bothered by the manor in which he appears to be getting there.
That is kinda funny but on the realistic side he will be issued more shares down the road.
I don't like this deal, not right now. Sure hope GC has something to announce next week or say on the call to change my mine.
Have blessed and safe holiday weekend!
Most of what you said is true. Time will tell if its a good move.
Understood. And to be honest jumping ship at .045 is probably not a wise move. But who knows.
I am honestly not sure what to think. GC has just done what he said repeatedly that he would not do!
Yes I think he has a plan and no I do not think he is dumb. He basically is saying to hell with the small retailers I only need the institutions and this move gets him that. Assuming they uplist quickly.
I am very aware of the math. And yes playing with the big boys means that actually SHORT stocks of companies with no money or revenue!!!
If GC doesn't announce something big this will get kicked right back down. This currently is only a RS, not an uplist yet.
When this opens in the $6 - $8 range and is still trading on the OTC what do you think is going to happen?
Only keeping it real and not going to sugar coat it. With what is known now this looks like a bad deal to me!
Yes GC and other insiders know something.
They know this move gets rid of the retailer investor which GC obviously has no interest in. It makes room for the institution to step in which is who GC wants.
Just too big of a split. And I don't feel the company is ready yet unless there is significant money at the door.
2 billion / 150 = 13,333,333 which is what the new structure would be.
I don't like it!
Not going to bail just yet. Thanks and better luck on the next one.
Calling this stock a scam is no better than people saying its going to the moon.
FYI investors aren't worried about one day.
Doesn't matter. The PPS was up ~50% in 5 days....the 10Q was a reason for traders to take profits. The chart was over bought, which I had pointed out also. Today was the second day the PPS opened well above the upper BB.
Stocks take the stairs up and the elevator down. Fear is a powerful emotion. This is why so many short post on days like today....didn't see them much the past 5 days while the PPS was climbing.
No help from the Fed. Looks like it's headed to .90 or lower.
You said "out of cash in 5 weeks". They don't have 5 weeks of "cash" on hand and never really have.
Your story is changing shorter.
World Class BOD/BOA. It's all about connection in the biotech world.
Agreed!! Common sense isn't so common.
AMBS has not attracted a world class team to play in the minor leagues. However it will take time to move the science forward.
Not hardly, It's basic math and reading....
During the first quarter of 2015 under the Lincoln Park Capital Fund LLC financing arrangement the Company sold 38,445,801 common shares and issued 493,436 common shares as a commitment fee for a total of $2,819. $14,506 funding remains available under the financing arrangement as of March 31, 2015.
Plenty of cash to operate.
Up 50% in 4 days
They have access to 12 million in funding already so no more needed.
Consolidation is caused by traders. The current run is based on company announcements and expected near term milestones. I disagree with your opinion on news. I think the latest news is value creating and sets the company up for big milestones such as first in human trails. That is a big deal as those trails can lead to partnerships.
I do agree it's nice to see the market absorbing the sellers nicely.
That one looks much clearer than mine....can I barrow it? lol
Maybe some consolidation today....maybe higher....ALL good over the coming months!
Only up approximately 50% in 4 days. So even IF it cools off no big deal, consolidation is good. Nothing new or surprising in the 10Q.
Good question but we don't have a full answer other than a portion of the money going to Lonza is to prepare ESS for the Phase 2 trail/study that is scheduled to start mid year.
I think there is more going on behind the scenes here with ESS.
Closed a $5 million Series G preferred stock financing on April 24, 2015;
Plus they have access to $12 million in funding from LPC.
AMBS can close the Lonza deal any time they want!
And just below that:
Other
Exploration of the Company’s PhenoGuard platform for neurrotrophic factor discovery and discovery and evaluation of external drug candidates for potential in-licensure or acquisition.
For the next 12 months, the Company intends to focus primarily on the commercialization of LymPro, the further clinical development of Eltoprazine, and the preclinical development of MANF.
It reads like any pre revenue biotech. No worries because that's all about to change. No one who is invested in AMBS is surprised by anything in the filing IMO.
And there you have it .07. Very impressive move with plenty more to come. Great to see AMBS move back toward where it should be.
You didn't answer my question but that's ok. The big picture will become clear...it already is to some.